Item 2.02. Results of Operations and Financial Condition.
On May 11, 2022, STRATA Skin Sciences, Inc. (the “Company”) issued a press
release announcing its results of operations for the first fiscal quarter ended
March 31, 2022. The full text of such press release is furnished as Exhibit 99.1
to this report.
The information set forth under this Item 2.02, including Exhibit 99.1, is being
furnished and shall not be deemed “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to the liabilities of such section, nor shall such information be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in any such filing.
Item 7.01. Regulation FD Disclosure.
On May 11, 2022, STRATA Skin Sciences, Inc. (the “Company”) issued a press
release announcing its results of operations for the first fiscal quarter ended
March 31, 2022. The full text of such press release is furnished as Exhibit 99.1
to this report.
The information set forth under this Item 7.01, including Exhibit 99.1, is being
furnished and shall not be deemed “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to the liabilities of such section, nor shall such information be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in any such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The following press release is furnished as an exhibit to this Current Report on
Form 8-K pursuant to Item 2.02 and shall not be deemed to be “filed”:
99.1 Press Release dated May 11, 2022 issued by STRATA Skin Sciences,
Inc.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
© Edgar Online, source Glimpses
postbrexitcompliance.com 